neurofilament phosphorylation
Recently Published Documents


TOTAL DOCUMENTS

67
(FIVE YEARS 0)

H-INDEX

25
(FIVE YEARS 0)

2017 ◽  
Vol 13 (7S_Part_27) ◽  
pp. P1305-P1306
Author(s):  
Miriam Barker ◽  
Leslie Bridges ◽  
Margaret Esiri ◽  
Atticus H. Hainsworth

PLoS ONE ◽  
2014 ◽  
Vol 9 (10) ◽  
pp. e110174 ◽  
Author(s):  
Nikki A. McLean ◽  
Bogdan F. Popescu ◽  
Tessa Gordon ◽  
Douglas W. Zochodne ◽  
Valerie M. K. Verge

PLoS ONE ◽  
2012 ◽  
Vol 7 (8) ◽  
pp. e43883 ◽  
Author(s):  
Wen-Ching Lee ◽  
Daphne Kan ◽  
Yun-Yu Chen ◽  
Shan-Kuo Han ◽  
Kuo-Shyan Lu ◽  
...  

2006 ◽  
Vol 12 (3) ◽  
pp. 325-328 ◽  
Author(s):  
A Petzold ◽  
M J Eikelenboom ◽  
G Keir ◽  
C H Polman ◽  
B MJ Uitdehaag ◽  
...  

This study investigated whether the new Global Multiple Sclerosis Severity Scale (MSSS) correlated with cerebrospinal fluid biomarkers for axonal and glial pathology. The MSSS correlated with the phosphorylated neurofilament heavy chain (NfH-SMI35, R=0.44, P=0.016). The degree of neurofilament phosphorylation (ratio NfH-SMI34 to NfH-SMI35) was 8-fold higher in severely (median MSSS 6.5) versus mildly (MSSS 3.2) disabled patients (7.3 versus 0.9, P=0.03). The MSSS may provide a statistically powerful tool for comparing overall disease severity and be useful for validating the biomarker concept in MS.


Sign in / Sign up

Export Citation Format

Share Document